Drospirenone Synthesis via Palladium-Catalyzed Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for producing drospirenone involve the use of carcinogenic reagents like chromium(VI) oxide or require sequential reagent additions and analytical controls, making them unsuitable for continuous industrial production.
Innovation Solution
A single-step process using gaseous oxygen in the presence of palladium in the +2 oxidation state, an organic base, and molecular sieves in an organic solvent at controlled temperatures to convert specific steroid compounds into drospirenone, eliminating the need for hazardous reagents and minimizing operator intervention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If chromium(VI) oxide is used as oxidant, then drospirenone can be produced through oxidation, but the process becomes unsuitable for industrial production due to carcinogenicity and legislative restrictions
Solution Approach 1:
The patent changes the chemical nature of the oxidant from chromium(VI) oxide to a catalytic system using palladium(II) acetate with oxygen. This parameter change eliminates carcinogenicity while maintaining oxidation capability, resolving the contradiction between ease of manufacture and harmful factors.
Solution Approach 2:
The patent uses oxygen as the terminal oxidant instead of stoichiometric chromium(VI) oxide. Oxygen is abundant, non-toxic, and the only byproduct is water, eliminating the need to handle and dispose of hazardous chromium waste, thus resolving the contradiction.
2Reliability
If sequential reagent additions and analytical controls are used, then oxidation can be completed, but the process cannot run continuously and operator intervention is required
Solution Approach 1:
The patent employs a catalytic system with palladium(II) acetate that enables continuous oxidation. The catalyst remains active throughout the reaction, allowing continuous processing without sequential additions or analytical controls, thus resolving the contradiction between reliability and productivity.
Solution Approach 2:
The catalytic system automatically maintains oxidation activity without requiring operator intervention for reagent additions or analytical checks. The system self-regulates the oxidation process, enabling continuous production and resolving the contradiction between reliability and productivity.
3Manufacturing precision
If multiple steps are used to remove metal catalysts, then product purity can be achieved, but the process becomes complex and time-consuming
Solution Approach 1:
The patent uses a non-metallic organic catalyst system (palladium(II) acetate with oxygen) that eliminates the need for metal catalyst removal. The catalytic system is designed to be easily separable or decomposable, simplifying purification and resolving the contradiction between product purity and process complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process allows for the efficient and safe production of drospirenone without carcinogenic reagents, simplifying the production process and enabling continuous operation by achieving high purity in a single step, thus overcoming the limitations of prior methods.
Implementation Method 1
using gaseous oxygen in the presence of a compound of palladium in the +2 oxidation state
Implementation Method 2
oxidation under heating of 17α-(3-hydroxypropyl)-6β,7β;15β,16β-dimethylene-5β-androstane-3β,5,17β-triol
Implementation Method 3
in the presence of a compound of palladium in the +2 oxidation state, an organic base and molecular sieves
Data Source
AI summary
A process is disclosed wherein, using either 17a-(3-hydroxypropyl)-6p,7p;15p,16p- dimethylene-5p-androstane-3p,5,17p-triol (II) or 3β,5^ΐΙ^κ^-6β,7β;15β,16β- dimethylene-5β,17α-pregnane-21,17-carbolactone (III) as starting material, through a single-step reaction it is obtained drospirenone (I), a synthetic steroid with progestogenic, antimineralocorticoid and antiandrogenic activity, useful for preparing pharmaceutical compositions with contraceptive action.